Heart Transplant - Heart Transplant - 474 · heart-transplant
    • CardiologyTalk

      Site: CardiologyTalk

    • Quick Links
      • Schedule An Interview
      • What Is Our Interview Process
    • 0
      • Portuguese
      • Spanish
      • Italian
      • Greek (Greece)
      • Sinhala
      • Polish
      • Arabic (Saudi Arabia)
      • Swedish (Sweden)
      • Portuguese (Brazil)
      • Hindi (India)
      • English (Australia)
      • Hebrew (Israel)
      • Czech
      • Hungarian (Hungary)
      • Chinese
      • Turkish
      • Japanese (Japan)
      • Dutch
      • French
      • German
      • Chinese (Traditional Han, Taiwan)
      • Korean (South Korea)
      • Thai
      • Spanish (Chile)
      • English (United States)
      • Russian
      • Danish (Denmark)
  • Home
  • Trending

  • Login

  • Audio and Video
  • Videos
  • Audio

  • Channels
  • Browse Channels

  • Categories
  • Acute Pulmonary Embolism 1
  • Amyloidosis 10
  • Angina 1
  • Anticoagulation Management 1
  • Aortic Stenosis 1
  • Arrhythmias and Clinical EP 2
  • Atrial Fibrillation 18
  • Autonomic Cardiology 1
  • Blood Pressure 1
  • Cardiac Implantable Electronic Devices 2
  • Cardiac Injury 3
  • Cardiac Surgery 13
  • Cardio-Oncology 17
  • Cardiogenic Shock 4
  • Cardiology 111
  • Cardiology Advocacy 16
  • Cardiomyopathy 5
  • Cardiorenal 2
  • Cardiorenal Syndrome 1
  • Cardiovascular Disease 17
  • Cardiovascular Imaging 2
  • Conference Coverage 63
  • Congenital Heart Disease 1
  • Coronary Artery Disease 11
  • Coronary Microvascular Dysfunction 3
  • Coronary Pharmacotherapy 1
  • Coronary Stent 2
  • COVID-19 81
  • Diabeto-Cardiology 2
  • Dyslipidemia 1
  • Echocardiograms 3
  • Heart Disease 1
  • Heart Failure and Cardiomyopathies 60
  • Heart Transplant 1
  • Heart Valve 3
  • Hemostasis 1
  • Hypertension 12
  • Hypertrophic Cardiomyopathy 2
  • Irregular Heart Rhythm 1
  • Ischemic Heart Disease 4
  • Myocardial Infarction 13
  • Prevention 4
  • Pulmonary Hypertension 2
  • Stroke 1
  • Structural Heart Disease 1
  • TAVR 3
  • Transcatheter Aortic Valve (TAVI) 3
  • Tricuspid Regurgitation 1
  • Valvular Heart Disease 2
  • Vasovagal Syncope 1
  • Ventricular Failure 1
  • Acute Coronary Syndromes 189

  • Install
  • Play a Link
  • About
  • Contact
Naga Dharmavaram, MD @NagaDharmavaram #UWMadison @uw_medicine @keckschool_USC @davebaran @sentarahealth #HeartTransplant #Cardiology #Research Hearts From Donors With A History Of Drug Us... Naga Dharmavaram, MD @NagaDharmavaram #UWMadison @uw_medicine @keckschool_USC @davebaran @sentarahealth #HeartTransplant #Cardiology #Research Hearts From Donors With A History Of Drug Us...
0:08:25

Naga Dharmavaram, MD @NagaDharmavaram #UWMadison @uw_medi...

Naga Dharmavaram, MD, a fellow at the University of Wisconsin Hospital and Clinics and colleagues speaks about Hearts From Donors With A History Of Drug Use Are Safe For Transplant.

Link to Abstract:
https://www.cardiovascularbusiness.com/topics/heart-failure/hearts-donors-history-drug-use-are-safe-transplant?utm_source=newsletter&utm_medium=cvb_news


Abstract -

Background: 
Prior research focused on historical data rather than looking at toxicological results at the time of organ donation. The goal of this study was to look at the long-term survival of heart transplants in the modern period, stratified by toxicological testing findings at the time of organ offer and comparing toxicology at the time of donation with factors based on reported history.

Methods: 
There were 23 748 adult heart transplants done between 2007 and 2017. A Toxicology Score was created using historical United Network for Organ Sharing data, and a Measured Toxicology Score was created using measured toxicology findings. The United Network for Organ Sharing Toxicology Score and Measured Toxicology Score, as well as Cox proportional hazards models with a range of risk variables, were used to look at survival.

Results: 
There were no changes in post-transplant death when using Cox proportional hazards models with toxicological and historical data. Toxicology-identified medication combinations were not linked to variations in survival. Lower donor age and ischemia duration were also shown to be substantially linked to survival (P0.0001).

Conclusions: 
Neither drug use history nor toxicological evidence of drug use was found to be linked with substantial variations in survival among donors approved for transplantation. Increasing the usage of these types of donors might assist to ease the persistent donor shortage.

17 Views
1 year Ago
Cardiology News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Heart Transplant Description
Heart Transplant

Naga Dharmavaram, MD @NagaDharmavaram #UWMadison @uw_medicine @keckschool_USC @davebaran @sentarahealth #HeartTransplant #Cardiology #Research Hearts From Donors With A History Of Drug Us... Naga Dharmavaram, MD @NagaDharmavaram #UWMadison @uw_medicine @keckschool_USC @davebaran @sentarahealth #HeartTransplant #Cardiology #Research Hearts From Donors With A History Of Drug Us...
0:08:25
Naga Dharmavaram, MD @NagaDharmavaram #UWMadison @uw_medi...
FHD
17 Views
1 year Ago
Cardiology News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

CardiologyTalk Copyright 2020